Fingolimod Capsule
Product Images NDC 65862-952

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 65862-952). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Time To 3-month Confirmed Disability Progression – Study 1 (itt Population) (Fingolimod Fig1)

Figure 1:   Time To 3-month Confirmed Disability Progression – Study 1 (itt Population) (Fingolimod Fig1)
A Kaplan-Meier curve chart titled 'Time to 3-Month Confirmed Disability Progression - Study 1 (ITT population)' showing the percentage of patients with disability progression over time (days). The graph compares Fingolimod 0.5 mg (solid line) versus Placebo (dashed line), with the placebo reaching about 24% and Fingolimod about 18% at the end of the study period around 700 days.*
FDA Label Image

Fig2 (Fingolimod Fig2)

Fig2 (Fingolimod Fig2)
Label for Fingolimod Capsules 0.5 mg by Aurobindo Pharma Limited, NDC 65862-952-30. The label states each capsule contains fingolimod hydrochloride USP 0.56 mg equivalent to fingolimod 0.5 mg. It includes storage instructions, pharmacist dispensing note, and distributor information for Aurobindo Pharma USA, Inc. The label also shows a barcode and a note about an overprinting zone.*
FDA Label Image

Fig3 (Fingolimod Fig3)

Fig3 (Fingolimod Fig3)
Fingolimod Capsules 0.5 mg oral dosage form packaging label from Aurobindo Pharma Limited, containing 7 unit-dose capsules. The label includes dosage strength 0.5 mg prominently and directs pharmacists to dispense the Medication Guide separately. Storage instructions note 20 to 25 degrees Celsius and child-resistant packaging is indicated.*
FDA Label Image

Chemical Structure (Fingolimod Str)

Chemical Structure (Fingolimod Str)
Chemical structure of Fingolimod, showing its molecular arrangement including an amine group with chloride ion, hydroxyl groups, a phenyl ring, and a long alkyl chain.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.